Korean J Urol.  1992 Feb;33(1):58-64.

A comparative study of cytostatic intravesical instillation for superficial bladder tumor

Affiliations
  • 1Department of Urology, Chonbuk National University Medical School Chonju, Korea.

Abstract

A total or 56 patients who underwent TUR-BT for superficial (stages O and A) bladder tumors received various chemoprophylactic treatment to prevent recurrence. 16 patients underwent resection only (Group I). Of the 56 patients treated with chemoprophylactic agents 18 patients were given thio-tepa at weekly interval for 8 weeks (Group 2). 20 patients were given adriamycin. weekly one time for 6 weeks (Group 3). 16 patients were given mitomycin C, weekly one time for 8 weeks (Group 4). All chemoprophylactic groups were followed by monthly one time for 1 year and the dosages of the used agents (thio-tepa, adriamycin and mitomycin C) were 60 mg/l dosage, 50 mg/l dosage and 30 ml/l dosage, respectively. During follow-up period (mean duration; 19.8-25. 2 months), 1umor recurred 56.2 % of group 1 patients, 27.7 % of group 2 patients, 25.0% of group 3 patients, 18.9 % of group 4 patients and 22.2% of total patients. Therefore three drugs were effective to decrease the recurrence rate of superficial bladder tumor and no significant differences in recurrence rate were noticed among drugs. Toxicity of the three agents were negligibly minimal except 2 patients who developed severe gross hematuria after adriamycin instillation.

Keyword

Superficial; Bladder tumor; Chemotherapy

MeSH Terms

Administration, Intravesical*
Doxorubicin
Drug Therapy
Follow-Up Studies
Hematuria
Humans
Mitomycin
Recurrence
Robenidine*
Thiotepa
Urinary Bladder Neoplasms*
Urinary Bladder*
Doxorubicin
Mitomycin
Robenidine
Thiotepa
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr